Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 4, 2001, Pages 580-584

  Sin, Don D ^a   Jack, V T U ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

Chronic obstructive pulmonary disease; Hospitalization; Inhaled corticosteroids; Mortality

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; FLUNISOLIDE; IPRATROPIUM BROMIDE; MACROLIDE; QUINOLONE DERIVATIVE; SULFANILAMIDE; TETRACYCLINE DERIVATIVE; THEOPHYLLINE DERIVATIVE; TRIAMCINOLONE;

ADULT; AGED; AGING; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DRUG EFFECT; ELDERLY CARE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

EID: 0035880882     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.4.2009033     Document Type: Article

References (45)

1. The impact of COPD on lung health worldwide; epidemiology and incidence
2. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study
3. Chronic obstructive pulmonary disease
4. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: A prospective randomised controlled trial
5. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease
6. Glucocorticoids in clinical practice
7. Inhaled glucocorticoids for asthma
8. Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease
9. Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease
10. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial
11. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease
12. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
13. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease N Engl J Med
14. A comparison of observational studies and randomized, controlled trials
15. Randomized, controlled trials, observational studies, and the hierarchy of research designs
16. Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease
17. Validity of the ischemic heat disease and chronic obstructive pulmonary disease in the Saskatchewan health care files
18. Trends in the epidemiology of COPD in Canada, 1980 to 1995
19. Oral corticosteroid treatment during long-term oxygen therapy in chronic obstructive pulmonary disease: A risk factor for hospitalization and mortality in women
20. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
21. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
22. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease
23. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease
24. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease
25. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study
26. The influence of an inhaled steroid on quality of life in patients with asthma or COPD
27. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
28. Prognosis in chronic obstructive pulmonary disease
29. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study. Risk of chronic obstructive pulmonary disease. 1996
30. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease
31. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease
32. Hyperresponsiveness as a determinant of the outcome in chronic obstructive pulmonary disease
33. Design issues for drug epidemiology
34. Oral corticosteroid treatment during long-term oxygen therapy in chronic obstructive pulmonary disease: A risk factor for hospitalization and mortality in women
35. Pitfalls in nonrandomized outcomes studies. The case of incidental appendectomy with open cholecystectomy
36. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma
37. The use of administrative data to risk-stratify asthmatic patients
38. Inhaled steroids and the risk of hospitalization for asthma
39. Low dose inhaled corticosteroids and the prevention of death from asthma
40. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population
41. Prehospitalization inhaled corticosteroid use in patients with COPD or asthma
42. Physician perceptions and management of COPD
43. Practical considerations on the use of the Charlson comorbidity index with administrative databases
44. The exclusion of the elderly and women from clinical trials in acute myocardial infarction